Sigma-Aldrich Corporation (Nasdaq: SIAL) announced on December 30 that it has acquired all outstanding shares of Cerilliant Corporation of Round Rock, Texas to strengthen the Company’s analytical chemistry product portfolio and to continue to deliver on its strategic growth plans. Cerilliant, a leading supplier of high-quality reference standards and materials, provides products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets.








